 |
 |

Prevention of Pain in Neonates
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: The prevention of pain in neonates should be the goal of all caregivers, but the evidence for improved clinical outcomes with adequate pain control in newborns has been limited. The results of the NEOPAIN trial, the largest randomized controlled trial to date to evaluate benefits of pain control in critically ill neonates, indicated that morphine infusion in ventilated preterm infants controlled pain but had no beneficial effects on pulmonary outcomes and neurological morbidities.1-2 The use of open-label morphine doses was associated with significant adverse effects.1-2 Potential long-term benefits of pain control on neurodevelopmental outcomes for these infants have not yet been assessed. Summary proceedings from the Neonatal Pain Control Group again identified significant gaps in knowledge and raised concerns about possible adverse effects of analgesic exposure on long-term global developmental outcomes.3
In the absence of a clear risk-benefit analysis favoring use of pharmacologic analgesics, it is concerning . . . [Full Text of this Article]
Praveen Kumar, MBBS, DCH, MD
p-kumar@northwestern.edu Department of Pediatrics Northwestern University Feinberg School of Medicine Chicago, Illinois
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED ARTICLE
Epidemiology and Treatment of Painful Procedures in Neonates in Intensive Care Units
Ricardo Carbajal, André Rousset, Claude Danan, Sarah Coquery, Paul Nolent, Sarah Ducrocq, Carole Saizou, Alexandre Lapillonne, Michèle Granier, Philippe Durand, Richard Lenclen, Anne Coursol, Philippe Hubert, Laure de Saint Blanquat, Pierre-Yves Boëlle, Daniel Annequin, Patricia Cimerman, K. J. S. Anand, and Gérard Bréart
JAMA. 2008;300(1):60-70.
ABSTRACT
| FULL TEXT
RELATED LETTER
Prevention of Pain in Neonates—Reply
Ricardo Carbajal and K. J. S. Anand
JAMA. 2008;300(19):2248-2249.
EXTRACT
| FULL TEXT
|